Guidelines for Antimicrobial Use in Cattle

Guide to Antimicrobial Use in Animals

Volumn , Issue , 2009, Pages 143-160

  Constable, Peter D ^a   Pyörälä, Satu ^b   Smith, Geoffrey W ^c  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial agent dosages administered intravenously, intramuscularly, subcutaneously or orally in cattle; Antimicrobial susceptibility testing and respiratory disease treatment in cattle; Antimicrobials in mastitis through IMM route; Appropriate antimicrobial use in common diseases of cattle; Bovine tuberculosis by mycobacterium bovis; Digital dermatitis (papillomatous digital dermatitis) lameness in dairy cattle; Guidelines to antimicrobial options for septic arthritis pathogens in ruminants; Oral antimicrobial use to prevent diarrhoea and better management; Septic or infectious arthritis common orthopaedic problem in calves and adult cattle; Septicaemia, calf diarrhoea, septic arthritis, infectious foot, pneumonia, metritis, mastitis

Indexed keywords

EID: 67649172040     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444302639.ch9     Document Type: Chapter

References (105)

1. Aldridge, B.M., Garry, F.B. and Adams, R. (1993). Neonatal septicemia in calves: 25 cases (1985-1990). J. Am. Vet. Med. Assoc. 203: 1324-9.
2. Fecteau, M.E., House, J.K., Kotarski, S.F. et al. (2003). Efficacy of ceftiofur for treatment of experimental salmonellosis in neonatal calves. Am. J. Vet. Res. 64: 918-25.
3. Thomas, E., Roy, O., Skowronski, V., et al. (2004). Comparative field efficacy study between cefquinome and gentamicin in neonatal calves with clinical signs of septicemia. Revue Méd. Vét. 155: 489-93.
4. Wenz, J.R., Barrington, G.M., Garry, F.B., et al. (2001). Bacteraemia associated with naturally occurring acute coliform mastitis in dairy cows. J. Am. Vet. Med. Assoc. 219: 976-81.
5. Smith, G.W., Constable, P.D. and Morin, D.E. (2001). Ability of hematologic and serum biochemical variables to differentiate Gram-negative and Grampositive mastitis in dairy cows. J. Vet. Intern. Med. 15: 394-400.
6. OIE (2006). Guidelines on the responsible and prudent use of antimicrobial agents in veterinary medicine. Available at: http://www.oie.int/eng/normes/mcode/en_ chapitre_3.9.3.htm Accessed 20 Februarys.
7. Constable, P.D. (2004). Antimicrobial use in the treatment of calf diarrhea. J. Vet. Intern. Med. 18: 8-17.
8. Fecteau, G., Van Metre, D.C., Pare, J., et al. (1997). Bacteriological culture of blood from critically ill neonatal calves. Can. Vet. J. 38: 95-100.
9. Lofstedt, J., Dohoo, I.R. and Duizer, G. (1999). Model to predict septicemia in diarrheic calves. J. Vet. Intern. Med. 13: 81-8.
10. Fecteau, G., Paré, J., Van Metre, D.C., et al. (1997). Use of a clinical sepsis score for predicting bacteremia in neonatal dairy calves on a calf rearing farm. Can. Vet. J. 38: 101-104.
11. Ortman, K. and Svensson, C. (2004). Use of antimicrobial drugs in Swedish dairy calves and replacement heifers. Vet. Rec. 154: 136-40.
12. Morley, P.S., Apley, M.D., Besser, T.E., et al. (2005). Antimicrobial drug use in veterinary medicine. J. Vet. Intern. Med. 19: 617s.
13. Berge, A.C.B., Moore, D.A. and Sischo, W.M. (2006). Field trial evaluating the influence of prophylactic and therapeutic antimicrobial administration on antimicrobial resistance of fecal Escherichia coli in dairy calves. Appl. Environ. Microbiol. 72: 3872-8.
14. Sato, K., Bartlett, P.C. and Saeed, M.A. (2005). Anti-microbial susceptibility of Escherichia coli isolates from dairy farms using organic versus conventional production methods. J. Am. Vet. Med. Assoc. 226: 589-94.
15. White, G., Piercy, D.W.T. and Gibbs, H.A. (1981). Use of a calf salmonellosis model to evaluate the therapeutic properties of trimethoprim and sulphadiazine and their mutual potentiation in vivo. Res. Vet. Sci. 31: 27-31.
16. Constable, P.D. (2003). Use of antibiotics to prevent calf diarrhea and septicemia. Bovine Practitioner 37(2): 137-42.
17. Berge, A.C.B., Moore, D.A. and Sischo, W.M. (2006). Prevalence and antimicrobial resistance patterns of Salmonella enterica in preweaned calves from dairies and calf ranches. Am. J. Vet. Res. 67: 1580-8.
18. Ziv, G., Nouws, J.F.M., Groothuis, D.G., et al. (1977). Oral absorption and bioavailability of ampicillin derivatives in calves. Am. J. Vet. Res. 38: 1007-13.
19. Reisinger, R.C. (1965). Pathogenesis and prevention of infectious diarrhea (scours) of newborn calves. J. Am. Vet. Med. Assoc. 147: 1377-86.
20. Dalton, R.G., Fisher, E.W. and McIntyre, W.I.M. (1960). Antibiotics and calf diarrhea. Vet. Rec. 72: 1186-99.
21. Berge, A.C.B., Lindeque, P., Moore, D.A., et al. (2005). A clinical trial evaluating prophylactic and therapeutic antibiotic use on health and performance of preweaned calves. J. Dairy Sci. 88: 2166-77.
22. Schifferli, D., Galeazzi, R.L., Nicolet, J., et al. (1982). Pharmacokinetics of oxytetracycline and therapeutic implications in veal calves. J. Vet. Pharmacol. Ther. 5: 247-57.
23. Palmer, G.H., Bywater, R.J. and Stanton, A. (1983). Absorption in calves of amoxycillin, ampicillin, and oxytetracycline in milk replacer, water, or an oral rehydration formulation. Am. J. Vet. Res. 44: 68-71.
24. Belli, P., Poumarat, F., Perrin, M. and Martel, J.L. (1993). Evaluation of the in vivo activity of enrofloxacin in experimental Mycoplasma bovis infection of calves. Med. Vet. 10: 85-91.
25. Grandemange, E., Gunst, S., Woehrle, F. and Boisrame, B. (2002). Field evaluation of the efficacy of Marbocyl(R) 2% in the treatment of infectious arthritis of calves. Irish Vet. J. 55: 237-40.
26. Gough, A.W., Kasali, O.B., Siglar, R.E. and Baragi, V. (1992). Quinolone arthropathy-acute toxicity to immature articular cartilage. Toxicol. Pathol. 20: 436-9.
27. Ayling, R.D., Baker, S.E., Peek, M.L., Simon, A.J. and Nicholas, R.A. (2000). Comparison of in vitro activity of danofloxacin, florfenicol, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis. Vet. Rec. 146: 745-7.
28. Rosenbusch, R.F., Kinyon, J.M., Apley, M., et al. (2005). In vitro antimicrobial inhibition profiles of Mycoplasma bovis isolates recovered from various regions of the United States from 2002 to 2003. J. Vet. Diag. Invest. 17: 436-41.
29. Francoz, D., Desrochers, A., Fecteau, G., Desautels, C., Latouche, J.S. and Fortin, M. (2005). Synovial fluid changes in induced infectious arthritis in calves. J. Vet. Intern. Med. 19: 336-43.
30. Sawant, A.A., Sordillo, L.M. and Jayarao, B.M. (2005). A survey on antibiotic usage in dairy herds in Pennsylvania. J. Dairy Sci. 88: 2991-9.
31. Britt, J.S., Carson, M.C., vanBredow, J.D. and Condon, R.J. (1999). Antibiotic residues in milk samples obtained from cows after treatment for papillomatous digital dermatitis. J. Am. Vet. Med. Assoc. 215: 833-6.
32. Guterbock, W.M., Borelli, C.L. and Read, D.H. (1996). Evaluation of four therapies of papillomatous digital dermatitis in dairy cattle. Bovine Proc. 28: 240-1.
33. Laven, R.A. (2006). Efficacy of systemic cefquinome and erythromycin against digital dermatitis in cattle. Vet. Rec. 159: 19-20.
34. Laven, R.A. and Proven, M.J. (2000). Use of an antibiotic footbath in the treatment of bovine digital dermatitis. Vet. Rec. 147: 503-6.
35. Tragesser, L.A., Wittum, T.E., Funk, J.A., Winokur, P.L. and Rajala-Schultz, P.J. (2006). Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows. Am. J. Vet. Res. 67: 1696-1700.
36. Zhao, S., Qaiyumi, S., Friedman, S., et al. (2003). Characterization of Salmonella enterica serotype Newport isolated from humans and food animals. J. Clin. Microbiol. 41: 5366-71.
37. Fey, P.D., Safranek, T.J., Rupp, M.E., et al. (2000). Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N. Engl. J. Med. 342: 1242-9.
38. Schwarz, S., Kehrenberg, C. and Walsh, T.R. (2001). Use of antimicrobial agents in veterinary medicine and food animal production. Int. J. Antimicrob. Agents 17: 431-7.
39. Murphy, G.L., Robinson, L.D. and Burrows, G.E. (1993). Restriction endonuclease analysis and ribotyping differentiate Pasteurella haemolytica serotype A1 isolates from cattle within a feedlot. J. Clin. Microbiol. 31: 2303-8.
40. Constable, P.D. (2004b). Use of susceptibility testing in veterinary medicin. Proceedings 37th Annual Convention, American Association Bovine Practitioners 37: 11-17.
41. Hjerpe, C.A. and Routen, T.A. (1976). Practical and theoretical considerations concerning treatment of bacterial pneumonia in feedlot cattle, with special reference to antimicrobic therapy. Proc. Ann. Conv. AABP, San Francisco 9: 142-7.
42. Martin, S.W., Meek, A.H. and Curtis, R.A. (1983). Antimicrobial use in feedlot calves: its association with culture rates and antimicrobial susceptibility. Can. J. Comp. Med. 47: 6-10.
43. Allen, J.W., Viel, L., Bateman, K.G., et al. (1992). Changes in the bacterial flora of the upper and lower respiratory tracts and bronchoalveolar lavage differential cell counts in feedlot calves treated for respiratory diseases. Can. J. Vet. Res. 56: 177-83.
44. Allen, J.W., Viel, L., Bateman, K.G., et al. (1991). The microbial flora of the respiratory tract in feedlot calves: associations between nasopharyngeal and bronchoalveolar lavage cultures. Can. J. Vet. Res. 55: 341-6.
45. Thomas, A., Dizier, I., Trolin, A., et al. (2002). Comparison of sampling procedures for isolating pulmonary mycoplasmas in cattle. Vet. Res. Comm. 26: 333-9.
46. Godinho, K.S., Sarasola, P., Renoult, E., et al. (2007). Use of deep nasopharyngeal swabs as a predictive diagnostic method for natural respiratory infections in calves. Vet. Rec. 160: 22-5.
47. Dohmen, M.J.W., Joop, K., Sturk, A., et al. (2000). Relationship between intra-uterine bacterial contamination, endotoxin levels, and the development of endometritis in postpartum cows with dystocia or retained placenta. Theriogenology 54: 1019-32.
48. Konigsson, K., Gustafsson, H., Gunnarsson, A., et al. (2001). Clinical and bacteriological aspects on the use of oxytetracycline and flunixin in primiparous cows with induced retained placenta and post-partal endometritis. Reprod. Dom. Anim. 36: 247-56.
49. Bretzlaff, K.N., Ott, R.S., Koritz, G.D., et al. (1983). Distribution of oxytetracycline in genital tract tissues of postpartum cows given the drug by intravenous and intrauterine routes. Am. J. Vet. Res. 44: 764-9.
50. Cohen, R.O., Ziv, G., Soback, S., et al. (1993). The pharmacology of oxytetracycline in the uterus of postparturient dairy cows with retained foetal membranes. Israel J. Vet. Med. 48: 69-79.
51. Zhou, C., Boucher, J.E. and Dame, K.J. (2001). Multilocation trial of ceftiofur for treatment of postpartum cows with fever. J. Am. Vet. Med. Assoc. 219: 805-8.
52. Drillich, M., Beetz, O., Pfützner, A., et al. (2001). Evaluation of a systemic antibiotic treatment of toxic puerperal metritis in dairy cows. J. Dairy Sci. 84: 2101-17.
53. Okker,H., Schmitt, E.J., Vos, P.L.A.M., et al. (2002). Pharmacokinetics of ceftiofur in plasma and uterine secretions and tissues after subcutaneous postpartum administration in lactating dairy cows. J. Vet. Pharmacol. Ther. 25: 33-8.
54. Callahan, C.J., Horstman, L.A. and Frank, D.J. (1988). A comparison of fenprostalene and oxytetracycline as treatment for retained fetal membranes in dairy cows. Bovine Pract. 23: 21-3.
55. Drillich, M., Mahistedt, M., Reichert, U., et al. (2006). Strategies to improve the therapy of retained fetal membranes in dairy cows. J. Dairy Sci. 89: 627-35.
56. Stevens, R.D., Dinsmore, R.P. and Cattell, M.B. (1995). Evaluation of the use of intrauterine infusions of oxytetracycline, subcutaneous injections of fenprostalene, or a combination of both, for the treatment of retained fetal membranes in dairy cows. J. Am. Vet. Med. Assoc. 207: 1612-5.
57. Leblanc, S.J., Duffield, T.F., Leslie, K.E., et al. (2002). The effect of treatment of clinical endometritis on reproductive performance in dairy cows. J. Dairy Sci. 85: 2237-49.
58. Scott, H.M., Schouten, M.J., Gaiser, J.C., et al. (2005). Effect of intrauterine administration of ceftiofur on fertility and risk of culling in postparturient cows with retained fetal membranes, twins, or both. J. Am. Vet. Med. Assoc. 226: 2044-52.
59. Fang, W. and Pyörälä, S. (1996). Mastitis causing Escherichia coli: serum sensitivity and susceptibility to selected antibacterials in milk. J. Dairy Sci. 79: 76-82.
60. Louhi, M., Inkinen, K., Myllys, V. and Sandholm, M. (1992). Relevance of sensitivity testings (MIC) of S. aureus to predict the antibacterial action in milk. J. Vet. Med. B 39: 253-62.
61. Sordillo, L. (2005). Factors affecting mammary gland immunity and mastitis susceptibility. Livestock Prod. Sci. 98: 89-99.
62. Constable, P.D. and Morin, D.E. (2002). Use of antimicrobial susceptibility testing of bacterial pathogens isolated from the milk of dairy cows with clinical mastitis to predict response to treatment with cephapirin and oxytetracycline. J. Am. Vet. Med. Assoc. 221: 103-8.
63. Constable, P.D. and Morin, D.E. (2003). Treatment of clinical mastitis. Using antimicrobial susceptibility profiles for treatment decisions. In: Sears P. Guest Editor, Bovine Mastitis. Vet. Clin. North Am. Food Anim. Practice 19: 139-55.
64. Olsen, J.E., Christensen, H. and Aarestrup, F.M. (2006). Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci. J. Antimicr. Chemother. 57: 450-60.
65. Pitkälä, A., Haveri, M., Pyörälä, S, Myllys, V. and Honkanen-Buzalski, T. (2004). Bovine mastitis in Finland 2001-prevalence, distribution of bacteria and antimicrobial resistance. J. Dairy Sci. 87: 2433-41.
66. Lehtolainen, T., Shpigel, N., Pohjanvirta, T., Pelkonen, S. and Pyörälä, S. (2003). In vitro antimicrobial susceptibility of Escherichia coli isolates originating from clinical mastitis in Finland and Israel. J. Dairy Sci. 86: 3927-32.
67. Morin, D.E., Shanks, R.D. and McCoy, G.C. (1998). Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis. J. Am. Vet. Med. Assoc. 213: 676-84.
68. Franklin, A., Holmberg, O., Horn af Rantzien, M. and Åström, G. (1984). Effect of procaine benzylpenicillin alone or in combination with dihydrostreptomycin on udder pathogens in vitro and in experimentally infected bovine udders. Am. J. Vet. Res. 45: 1398-1402.
69. Franklin, A., Horn af Rantzien, M., Obel, N., Östensson, K., Åström, G. and Rantzien, M.H. (1986). Concentrations of penicillin, streptomycin, and spiramycin in bovine udder tissue liquids. Am. J. Vet. Res. 47: 804-7.
70. Moretain, J.P. and Boisseau, J. (1989). Excretion of penicillins and cephalexin in bovine milk following intramammary administration. Food Add. Contamin. 6: 79-90.
71. Ehinger, A.M. and Kietzmann, M. (2000). Tissue distribution of oxacillin and ampicillin in the isolated perfused bovine udder. J. Vet. Med. A 47: 157-68.
72. Ullberg, S., Hansson, E. and Funke, H. (1958). Distribution of penicillin in mastitic udders following intramammary injection-an autoradiographic study. Am. J. Vet. Res. 19: 84-92.
73. Anonymous (2003). Use of antimicrobial agents in animals. Report of the working group on antimicrobial agents. Ministry of Agriculture and Forestry in Finland. MAFF Publications 9, 2003. Available at: http://www.mmm.fi/julkaisut/tyoryhmamuistiot/2003/tr2003_9a.pdf. Accessed 20 February.
74. Raymond, M.J., Wohlre, R.D. and Call, D.R. (2006). Assessment and promotion of judicious antibiotic use on dairy farms in Washington State. J. Dairy Sci. 89: 3228-40.
75. Ziv, G. (1980). Drug selection and use in mastitis: systemic vs. local therapy. J. Am. Vet. Med. Assoc. 176: 1109-15.
76. Duenas, M.I., Paape, M.J., Wettemann, R.P. and Douglass, L.W. (2001). Incidence of mastitis in beef cows after intramuscular administration of oxytetracycline. J. Anim. Sci. 79: 1996-2005.
77. Erskine, R.J. and Barlett, P.C. (1996). Intramuscular administration of ceftiofur sodium versus intramammary infusion of penicillin/novobiocin for treatment of Streptococcus agalactiae mastitis in dairy cows. J. Am. Vet. Med. Assoc. 208: 258-60.
78. Kaartinen, L., Löhönen, K., Wiese, B., Franklin, A. and Pyörälä, S. (1999). Pharmacokinetics of sulphadiazinetrimethoprim in lactating dairy cows. Acta Vet. Scand. 40: 271-8.
79. Lents, C.A., Wettemann, R.P., Paape, M.J., et al. (2002). Efficacy of intramuscular treatment of beef cows with oxytetracycline to reduce mastitis and to increase calf growth. J. Anim. Sci. 80: 1405-12.
80. Owens, W.E., Nickerson, S.C. and Ray, C.H. (1999). Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation. J. Dairy Sci. 82: 645-7.
81. Shpigel, N.Y., Winkler, M., Ziv, G., et al. (1998). Relationship between in vitro sensitivity of coliform pathogens in the udder and the outcome of treatment for clinical mastitis. Vet. Rec. 142: 135-7.
82. Erskine, R.J., Barlett, P.C., VanLente, J.L. and Phipps, C.R. (2002). Efficacy of systemic ceftiofur for severe clinical mastitis in dairy cattle. J. Dairy Sci. 85: 2571-5.
83. Sanders, P., Moulin, G., Guillot, P., et al. (1992). Pharmacokinetics of spiramycin after intravenous, intramuscular and subcutaneous administration in lactating cows. J. Vet. Pharmacol. Ther. 15: 53-61.
84. Pyörälä, S. and Pyörälä, E. (1998). Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995). J. Am. Vet. Med. Assoc. 212: 407-12.
85. Waage, S. (1997). Comparison of two regimens for the treatment of clinical bovine mastitis caused by bacteria sensitive to penicillin. Vet. Rec. 141: 616-20.
86. Taponen, S., Jantunen, A., Pyörälä, E. and Pyörälä, S. (2003). Efficacy of targeted 5-day parenteral and intramammary treatment of clinical Staphylococcus aureus mastitis caused by penicillin-susceptible or penicillin-resistant bacterial isolate. Acta Vet. Scand. 44: 53-62.
87. Ziv, G. and Storper, M. (1985). Intramuscular treatment of subclinical staphylococcal mastitis in lactating cows with penicillin G, methicillin and their esters. J. Vet. Pharmacol. Ther. 8: 276-83.
88. Whittem, T. and Hanlon, D. (1997). Dihydrostreptomycin or streptomycin in combination with penicillin in dairy cattle therapeutics: a review and re-analysis of published data, Part 1: Clinical pharmacology. New Zealand Vet. J. 45: 178-84.
89. Erskine, R.J. (2003). Antibacterial therapy of clinical mastitis-part I. Drug selection. Part II Administration. North Am. Vet. Conf. Proceedings 17: 13-16.
90. Barkema, H., Schukken,Y.H. and Zadoks, R.N. (2006). Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J. Dairy Sci. 89: 1877-95.
91. Jones, G.F. and Ward, G.E. (1990). Evaluation of systemic administration of gentamicin for treatment of coliform mastitis in cows. J. Am. Vet. Med. Assoc. 197: 731-5.
92. Pyörälä, S., Kaartinen, L., Käck, H. and Rainio, V. (1994b). Efficacy of two therapy regimes for treatment of experimentally induced Escherichia coli mastitis in the bovine. J. Dairy Sci. 77: 453-61.
93. Dosogne, H., Meyer, E., Sturk, A., et al. (2002). Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis. Inflammation Res. 51: 201-5.
94. Rantala, M., Kaartinen, L., Välimäki, E., et al. (2002). Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J. Vet. Pharm. Ther. 25: 251-8.
95. Shpigel, N.Y., Levin, D., Winkler, M., et al. (1997). Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. J. Dairy Sci. 80: 318-23.
96. Taponen, S., Dredge, K., Henriksson, B., et al. (2002). Efficacy of intramammary treatment with procaine penicillin G vs. procaine penicillin plus neomycin in bovine clinical mastitis caused by penicillin-susceptible, gram-positive bacteria-a double blind field study. J. Vet. Pharm. Ther. 26: 193-8.
97. Oliver, S.P., Almeida, R.A., Gillespie, B.E., et al. (2004). Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle. J. Dairy Sci. 87: 3322-9.
98. Shephard, R.W., Malmo, J. and Pfeiffer, D.U. (2000). A clinical trial to evaluate the effectiveness of antibiotic treatment of lactating cows with high somatic cell counts in their milk. Aust. Vet. J. 78: 763-8.
99. Wilson, D.J., Gonzalez, R.N., Case, K.L., Garrison, L.L. and Grohn, Y.T. (1999). Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. J. Dairy Sci. 82: 1664-70.
100. Swinkels, J.M., Hogeveen, H. and Zadoks, R.N. (2005a). A partial budget model to estimate economic benefits of lactational treatment of subclinical Staphylococcus aureus mastitis. J. Dairy Sci. 88: 4273-87.
101. Swinkels, J.M., Rooijendijk, J.G.A., Zadoks, R.N. and Hogeveen, H. (2005b). Use of partial budgeting to determine the estimate economic benefits of antibiotic treatment of chronic subclinical mastitis caused by Streptococcus uberis or Streptococcus dysgalactiae. J. Dairy Res. 72: 75-85.
102. Østerås, Edge V.L. and Martin, S.W. (1999). Determinants of success or failure in the elimination of major mastitis pathogens in selective dry cow therapy. J. Dairy Sci. 82: 1221-31.
103. Huijps, K. and Hogeveen, H. (2007). Stochastic modeling to determine the economic effects of blanket, selective, and no dry cow therapy. J. Dairy Sci. 90: 1225-34.
104. Robert, A., Seegers, H. and Bareille, N. (2006). Incidence of intramammary infections during the dry period without or with antibiotic treatment in dairy cows-a quantitative analysis of published data. Vet. Res. 37: 25-48.
105. Borm, A.A., Fox, L.K., Leslie, K.E., et al. (2006). Effects of prepartum intramammary antibiotic therapy on udder health, milk production, and reproductive performance in dairy heifers. J. Dairy Sci. 89: 2090-8.